Results 131 to 140 of about 4,485 (189)

<i>Ex vivo</i> and <i>in vivo</i> HIV-1 latency reversal by "Mukungulu," a protein kinase C-activating African medicinal plant extract. [PDF]

mBio
Richard K, Yuan Z, Tang H-Y, Goldman AR, Kuthu R, Raphane B, Register ET, Sharma P, Ross BN, Morris J, Williams DE, Cheney C, Wu G, Mounzer K, Laird GM, Zuck P, Andersen RJ, Simonambango S, Andrae-Marobela K, Tietjen I, Montaner LJ.   +20 more
europepmc   +1 more source

Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal. [PDF]

Antimicrob Agents Chemother, 2018
Spivak AM, Nell RA, Petersen M, Martins L, Sebahar P, Looper RE, Planelles V.   +6 more
europepmc   +1 more source

Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells. [PDF]

Cell Death Discov
Hajikhezri Z, Zygouras I, Sönnerborg A, van Domselaar R.   +3 more
europepmc   +1 more source

Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4⁺ T cell activation and HIV-1 latency reversal. [PDF]

Sci Adv, 2019
Cao S, Slack SD, Levy CN, Hughes SM, Jiang Y, Yogodzinski C, Roychoudhury P, Jerome KR, Schiffer JT, Hladik F, Woodrow KA.   +10 more
europepmc   +1 more source

HIV_GKO: A Tool to Assess HIV-1 Latency Reversal Agents in Human Primary CD4⁺ T Cells. [PDF]

Bio Protoc, 2018
Battivelli E, Verdin E.
europepmc   +1 more source

Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. [PDF]

J Clin Invest, 2017
Martin AR, Pollack RA, Capoferri A, Ambinder RF, Durand CM, Siliciano RF.   +5 more
europepmc   +1 more source

Integration site-independent enhancement of latency reversal by HIV-1 Nef

Journal of Virus Eradication, 2017
X.T. Kuang, S.W. Jin, T.M. Markle, M.A. Brockman   +3 more
openaire   +2 more sources

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems. [PDF]

PLoS One, 2016
Bialek JK, Dunay GA, Voges M, Schäfer C, Spohn M, Stucka R, Hauber J, Lange UC.   +7 more
europepmc   +1 more source

Novel use of alprazolam as a potential HIV-1 latency reversing agent

Journal of Virus Eradication, 2017
W. Elbezanti, A. Lin, S. Luca, F. Maldarelli, Z. Klase   +4 more
openaire   +2 more sources

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure

Journal of Virus Eradication, 2017
Michaela Madlenakova, Prakash Shankaran, Vera Hajkova, David Jilich, Ladislav Machala, Pavel Martasek, Zora Melkova   +6 more
openaire   +2 more sources